CORD BLOOD STEM CELLS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-191359 | Biotechnology
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Cord Blood Stem Cells Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL CORD BLOOD STEM CELLS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CORD BLOOD STEM CELLS MARKET
7.1 GLOBAL CORD BLOOD STEM CELLS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA CORD BLOOD STEM CELLS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 CyGenics Ltd
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Genecell International LLC (GCI)
16.3 BioCord
16.4 Kaneka Corporation
16.5 Angel Biotechnology
16.6 BioCell Pty. Ltd.
16.7 Future Health Technologies
16.8 CorCell
16.9 Geron Corporation
16.10 Banco De Cordon Umbilical
16.11 AlphaCord
16.12 J.P. McCarthy Cord Stem Cell Bank
16.13 Cord Blood America Inc.
16.14 Cells for Life
16.15 Activision Life SA
16.16 Babycord Jordan
16.17 Banco De Celulas Madre
16.18 Family CB Services
16.19 Cord Bank
16.20 Becton, Dickinson and Company
16.21 Advanced Cell Technology, Inc.
16.22 Golden MediTech Company
16.23 DomaniCell, LLC
16.24 Carolinas CBB
16.25 Cytolon AG
16.26 HemaStem Therapeutics
16.27 Eticur
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Most important types of Cord Blood Stem Cells products covered in this report are:Allogeneic Procedures
Autologous Procedures
Most widely used downstream fields of Cord Blood Stem Cells market covered in this report are:
Neurology
Oncology
Cardiology
Cartilage
Blood Disorders
Diabetes
Companies
CyGenics Ltd
Genecell International LLC (GCI)
BioCord
Kaneka Corporation
Angel Biotechnology
BioCell Pty. Ltd.
Future Health Technologies
CorCell
Geron Corporation
Banco De Cordon Umbilical
AlphaCord
J.P. McCarthy Cord Stem Cell Bank
Cord Blood America Inc.
Cells for Life
Activision Life SA
Babycord Jordan
Banco De Celulas Madre
Family CB Services
Cord Bank
Becton, Dickinson and Company
Advanced Cell Technology, Inc.
Golden MediTech Company
DomaniCell, LLC
Carolinas CBB
Cytolon AG
HemaStem Therapeutics
Eticur
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.